Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aspergillus fumigatus antigens represent a heterogeneous group of molecules, including cell wall polysaccharides and secreted proteins, that are critical to the lifecycle and pathogenicity of the fungus. Major structural antigens such as galactomannan and (1→3)-β-D-glucan are essential for maintaining fungal cell wall integrity and serve as the primary biomarkers for the clinical diagnosis of invasive aspergillosis (Maertens et al., 2005; Odabasi et al., 2004). Secreted proteins like Asp f 1 (a ribotoxin) and Asp f 3 (a peroxiredoxin) are potent allergens and virulence factors that facilitate tissue invasion and host immune modulation (Latgé & Steinbach, 2009). These antigens are primary targets for the development of diagnostic assays, monoclonal antibodies, and vaccine candidates designed to neutralize fungal toxins or promote immune-mediated clearance. In allergic manifestations like ABPA, these antigens trigger significant IgE-mediated inflammatory responses, making them indirect targets for biological therapies that modulate the host immune environment (Cassanova-Cardoso et al., 2020).
Opsonization and enhanced phagocytosis by the immune system; neutralization of fungal ribotoxins; inhibition of fungal cell wall synthesis; sequestering of IgE to prevent mast cell degranulation in allergic responses.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aspergillus fumigatus antigens (A. fumigatus antigens).